| | | | | |
GHRS GH Research PLC Ordinary Shares | €19,2576 | -3,28% | €1,27B | €133,87K | |
GBX The Greenbrier Companies, Inc. | €41,5600 | +0,04% | €1,27B | €64,56K | |
| €33,5998 | +2,70% | €1,27B | €126,89K | |
QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund - Shares of Beneficial Interest | €26,6330 | -0,05% | €1,27B | €48,61K | |
CBL CBL & Associates Properties, Inc. | €40,8831 | +0,73% | €1,27B | €346,45K | |
| €6,4464 | +1,83% | €1,26B | €6,64M | |
MBX MBX Biosciences, Inc. Common Stock | €27,4036 | +0,35% | €1,26B | €311,14K | |
URGN UroGen Pharma Ltd. Ordinary Shares | €25,2680 | -0,28% | €1,26B | €271,92K | |
| €23,6915 | -4,37% | €1,26B | €592,79K | |
NVGS NAVIGATOR HOLDINGS LTD. | €19,3609 | -3,43% | €1,26B | €234,12K | |
CMPS COMPASS Pathways Plc American Depository Shares | €10,1363 | -3,60% | €1,26B | €2,11M | |
| €40,7042 | -1,73% | €1,25B | €62,72K | |
ARI APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. | €9,4224 | -0,77% | €1,25B | €947,24K | |
| €8,7171 | -0,74% | €1,25B | €865,59K | |
| €32,2021 | +0,43% | €1,25B | €131,36K | |
